These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25526480)

  • 1. Post-transplant malignancy in liver transplantation: a single center experience.
    Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
    Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancy post-liver transplantation: a single center, population controlled study.
    Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
    Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
    Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
    Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
    Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
    Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
    Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.
    Chen YC; Cheng CH; Wang YC; Wu TJ; Chou HS; Chan KM; Lee WC; Lee CF; Soong RS
    Medicine (Baltimore); 2016 Sep; 95(37):e4901. PubMed ID: 27631265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
    Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
    Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience.
    Wahab MA; Abdel-Khalek EE; Elshoubary M; Yassen AM; Salah T; Sultan AM; Fathy O; Elmorshedi M; Shiha U; Elsadany M; Adly R; Samy M; Shehta A
    Transplant Proc; 2021 Mar; 53(2):636-644. PubMed ID: 33549346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
    Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
    Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancies after liver transplantation: a single-center experience.
    Hegab B; Khalaf H; Allam N; Azzam A; Al Khail FA; Al-hamoudi W; Kamel Y; Al Bahili H; Al Sofayan M; Al-Sebayel M
    Ann Saudi Med; 2012; 32(4):355-8. PubMed ID: 22705604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between infectious event and de novo malignancy after heart transplantation.
    Bujo C; Amiya E; Hatano M; Tsuji M; Maki H; Ishida J; Ishii S; Narita K; Endo M; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
    Heart Vessels; 2021 Apr; 36(4):499-508. PubMed ID: 33140148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort.
    Lucidi C; Biolato M; Lai Q; Lattanzi B; Lenci I; Milana M; Lionetti R; Liguori A; Angelico M; Tisone G; Avolio AW; Agnes S; Rossi M; Grieco A; Merli M
    Ann Hepatol; 2021; 24():100309. PubMed ID: 33482364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.